Korro Bio (KRRO) Other Non-Current Liabilities (2021 - 2026)

Korro Bio's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• Quarterly Other Non-Current Liabilities rose 1.39% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 1.39% YoY) and the FY2025 annual result came in at $1.5 million, up 0.61% from the prior year.
• Other Non-Current Liabilities was $1.5 million for Q1 2026 at Korro Bio, down from $1.5 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $1.5 million in Q3 2025 and bottomed at $57000.0 in Q1 2022.
• A 5-year average of $990692.3 and a median of $1.2 million in 2024 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities slumped 82.56% — and 2025, when it soared 113.67%.
• Korro Bio's Other Non-Current Liabilities stood at $79000.0 in 2022, then jumped by 1232.91% to $1.1 million in 2023, then jumped by 39.79% to $1.5 million in 2024, then rose by 0.61% to $1.5 million in 2025, then fell by 1.28% to $1.5 million in 2026.
• Business Quant data shows KRRO's Other Non-Current Liabilities at $1.5 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.